Home/ Supplements/ Reishi/ Hepatatone Plus

Hepatatone Plus

product on market Capsule Designs for Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines milk thistle and N-acetyl-cysteine, which have moderate evidence for supporting liver function and detoxification. Reishi and cordyceps mushrooms provide additional immune support, while Chinese skullcap is used for its antioxidant properties. Overall, clinical evidence for this specific combination of ingredients remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Hepatatone Plus
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
12%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 340.0mg (243 products) 3 studies — no high-quality reviews
CordycepsPrime(TM)
450 mg
N-Acetyl-Cysteine
400 mg
400 mg
Market median: 250.0mg (562 products) 55 studies (A:0, B:19)
Chinese Skullcap Extract
300 mg
Market median: 650.0mg (87 products) 1 studies — no high-quality reviews
Market median: 425.0mg (88 products)
Picrorhiza Extract
250 mg

Other Ingredients

Microcrystalline Cellulose Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take four capsules per day, or as directed by your health care practitioner.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Formulation Notes

Does not contain gluten.

Additional Information

HEP120

Notice: Color, size or shape may appear different between lots.

For Professional Use Only

Guaranteed GMP COMPLIANT Products

Manufactured in an NSF GMP Registered Facility

STORE IN A COOL, DRY PLACE.

Metadata

Product Details

UPC / SKU8 79452 00352 1
DSLD Entry Date2013-07-25
Product TypeOther Combinations
FormCapsule
DSLD ID23543
Data Updated2026-04-11
Research

Research Evidence

6
Research Sources
60
Avg Quality
3
Meta Analysis
3
Rct
B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients
Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 PubMed DOI
C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India
Rct International journal of medicinal mushrooms 2024 PubMed DOI
C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial
Rct Integrative cancer therapies 2020 PubMed DOI
View all evidence for Reishi →
Compare

Similar Products

View all Reishi products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.